Clinical Trials Logo

Clinical Trial Summary

The researchers involved in this new study are interested in whether giving a HPV vaccine to women at the same time as conisation can lead to a greater rate of HPV clearance compared to conisation on its own, and a result reduce the occurrence of further infection and high grade CIN. The study will do this by using a specific HPV vaccine called Gardasil 9™ which protects against 9 types of HPV infection (types 6, 11, 16, 18, 31, 33, 45, 52 and 58).


Clinical Trial Description

The human papilloma virus (HPV) can cause high grade intra-epithelial neoplasia (CIN) in women, a condition where there are abnormal cells on the surface of the cervix (the opening to the vagina from the womb). High grade CIN can develop into cervical cancer, and standard treatment is a surgical procedure called conisation, where a scalpel or laser is used to remove a cone-shaped piece of the cervix containing the abnormal cells. HPV vaccines are routinely used in adolescent girls as part screening programmes to prevent cervical cancer (12-18 years of age in the UK).

The NOVEL study will compare the vaccine approach with standard treatment in a randomised controlled trial, where eligible women will be randomly allocated to one of the following:

Arm 1: Local Cervical treatment and vaccination with Gardasil 9, followed by additional vaccinations 2 and 6 months after conisation Arm 2: Local Cervical Treatment and Observation

This study is for women aged 18-55 years of age with biopsy confirmed high-grade CIN. 1000 women will be recruited at colposcopy clinics in the UK, Finland and Sweden. Women will be followed up for a maximum of two and a half years. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03979014
Study type Interventional
Source Imperial College London
Contact Mathew Furtado
Phone +44 (0) 20 3311 7046
Email m.furtado@imperial.ac.uk
Status Not yet recruiting
Phase Phase 3
Start date November 1, 2019
Completion date July 31, 2023

See also
  Status Clinical Trial Phase
Completed NCT00339989 - Cervical Cancer Early Endpoints and Determinants
Completed NCT01954836 - Short-Term Fasting During Chemotherapy in Patients With Gynecological Cancer- a Randomized Controlled Cross-over Trial N/A
Completed NCT02065297 - Quantitative and Functional Study of TH17 Lymphocytes in Horton's Disease (HD)
Recruiting NCT02049645 - The Suitability of Sniff Dog as a Tool in Screening Tumors
Recruiting NCT02049658 - The Sensitivity and Specificity of Sniff Dog as a Tool in Diagnosing the Suspected Tumor Patients
Completed NCT01523912 - Radiofrequency Ablation for the Treatment of Gastric Dysplasia Phase 4
Completed NCT03415126 - A Study of ASN007 in Patients With Advanced Solid Tumors Phase 1
Enrolling by invitation NCT00792649 - Comparison Between HD+ Endoscopy and Standard Videoendoscopy in Screening Colonoscopy N/A
Recruiting NCT05158712 - Genetic Factors and Pheochromocytomas in Neoplasia Type 2
Completed NCT01962103 - Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors Phase 1/Phase 2
Terminated NCT01456143 - Optical Imaging of Head and Neck Cancer N/A
Recruiting NCT04341181 - ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling Phase 2
Recruiting NCT02925234 - The Drug Rediscovery Protocol (DRUP Trial) Phase 2